logo
Search…
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Search...
search
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Home > Latest

In the morning of December 2nd, Chaoju Ophthalmology (02219.HK) spent HK$325,000 to repurchase 120,000 shares.

date
02/12/2025
Intelligence Finance and Economics APP news, Chaoju Ophthalmology (02219.HK) announced that on December 2, 2025, the company spent 325,000 Hong Kong dollars to repurchase 120,000 shares.
Latest
2 m ago
Australia Reserve Bank's interest rate hike expectations rising, fear of increased selling of Australian government bonds.
2 m ago
China Passenger Car Association: Tesla sold 86,700 domestically produced cars in November.
2 m ago
A-Shi Chuang: plans to issue shares to specific entities to raise funds of no more than 900 million yuan.
2 m ago
Renfu Pharmaceutical (600079.SH) subsidiary withdraws registration application for recombination plasmid - Hepatocyte growth factor injection
2 m ago
National Energy Administration: In October, a total of 5,358 new renewable energy projects were added nationwide under the registered poverty alleviation program.
See all latestmore
logo
Contact US
qr
+852 - 60190728
gmteight@futurecultural.com
Customer Support
About Us
Contact Us
Frequently Asked
Privacy Policy
Terms of Use
Commercial Services
Advertising
Business Development
Copyright
Terms of Service
©️2013 - 2025 GMT EIGHT Holdings. All Rights Reserved.